Li, Siying
Guo, Lili
Zhou, Pingping
Tang, Jiyang
Wang, Zongyi
Zhang, Linqi
Zhao, Mingwei
Qu, Jinfeng
Clinical trials referenced in this document:
Documents that mention this clinical trial
Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
https://doi.org/10.1186/s40662-022-00316-z
Funding for this research was provided by:
Capital Clinical Diagnosis and Treatment Technology Research and Demonstration Application Project of China. (Z191100006619029)
National Key R&D Program of China (No.2020YFC2008200)
Article History
Received: 25 June 2022
Accepted: 5 November 2022
First Online: 1 December 2022
Declarations
:
: This study was approved by the Ethics Committee Review Board of Peking University People’s Hospital (2021PHB405-001). All patients provided written informed consent before surgery. All procedures adhered to the tenets of the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.